ArticleFrontiers in medicine2022

Efficacy of Red Blood Cell Exchange as Adjunctive Treatment for Hypoxemia and Survival Rate of Patients With Severe Coronavirus-2 Disease: An Open-Labeled Phase 2 Randomized Clinical Trial.

Mohammad Aminianfar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.